PD-L1 expression on NSCLC lung tumors is affected by the presence of COPD.

被引：0
|
作者：
Tine, Mariaenrica [1 ]
Semenzato, Umberto [1 ]
Ferrara, Martina Maria [1 ]
Frasson, Giulia [1 ]
Biondini, Davide [1 ]
Damin, Marco [1 ]
Pezzuto, Federica [1 ]
Calabrese, Fiorella [1 ]
Baraldo, Simonetta [1 ]
Cosio, Manuel G. [2 ]
Saetta, Marina [1 ]
Ferrara, Martina Maria [1 ]
机构：
[1] Univ Padua, Dept Cardiac Thorac Vasc Sci & Publ Hlth, Padua, PD, Italy
[2] McGill Univ, Resp Div, Meakins Christie Labs, Montreal, PQ, Canada
来源：
EUROPEAN RESPIRATORY JOURNAL | 2023年 / 62卷
关键词：
D O I：
10.1183/13993003.congress-2023.PA1708
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [21] PD-L1 Expression in Inflammatory Myofibroblastic Tumors
    Cottrell, Tricia R.
    Gocke, Christopher D.
    Xu, Haiying
    Ogurtsova, Aleksandra
    Taube, Janis M.
    Belchis, Deborah
    MODERN PATHOLOGY, 2017, 30 : 14A - 14A
  • [22] PD-L1 expression in inflammatory myofibroblastic tumors
    Cottrell, Tricia R.
    Duong, Anh T.
    Gocke, Christopher D.
    Xu, Haiying
    Ogurtsova, Aleksandra
    Taube, Janis M.
    Belchis, Deborah A.
    MODERN PATHOLOGY, 2018, 31 (07) : 1155 - 1163
  • [23] PD-L1 Expression in Inflammatory Myofibroblastic Tumors
    Cottrell, Tricia R.
    Gocke, Christopher D.
    Xu, Haiying
    Ogurtsova, Aleksandra
    Taube, Janis M.
    Belchis, Deborah
    LABORATORY INVESTIGATION, 2017, 97 : 14A - 14A
  • [24] PD-L1 expression and genotype in Non-Small Cell Lung Cancer (NSCLC)
    Ansen, S.
    Schultheis, A.
    Hellmich, M.
    Leenders, F.
    Zander, T.
    Michels, S.
    Brockmann, M.
    Stoelben, E.
    Groen, H.
    Timens, W.
    Buettner, R.
    Thomas, R. K.
    Perner, S.
    Wolf, J.
    ONCOLOGY RESEARCH AND TREATMENT, 2014, 37 : 5 - 6
  • [25] PD-L1 expression and genotype in non-small cell lung cancer (NSCLC).
    Ansen, Sascha
    Schultheis, Anne Maria
    Hellmich, Martin
    Zander, Thomas
    Brockmann, Michael
    Stoelben, Erich
    Groen, Harry J. M.
    Timens, Wim
    Buettner, Reinhard
    Thomas, Roman K.
    Perner, Sven
    Wolf, Juergen
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [26] PD-L1 in NSCLC cytology
    Kovacevic, M.
    Kern, I.
    Gabric, S.
    ANNALS OF ONCOLOGY, 2017, 28
  • [27] Circulating PD-L1 in NSCLC patients and the correlation between the level of PD-L1 expression and the clinical characteristics
    Zhang, Jie
    Gao, Jing
    Li, Yanyan
    Nie, Jun
    Dai, Ling
    Hu, Weiheng
    Chen, Xiaoling
    Han, Jindi
    Ma, Xiangjuan
    Tian, Guangming
    Wu, Di
    Shen, Lin
    Fang, Jian
    THORACIC CANCER, 2015, 6 (04) : 534 - 538
  • [28] Expression of PD-L1 in plasma exosomes of NSCLC patients and its associations with PD-L1 expression of corresponding tumour tissues
    Yu, S.
    Shi, M.
    Feng, J.
    ANNALS OF ONCOLOGY, 2019, 30
  • [29] PD-L1 EXPRESSION IN SUBTYPES OF ADENOCARCINOMA OF THE LUNG
    Son, Choonhee
    CHEST, 2019, 156 (04) : 307A - 307A
  • [30] Longitudinal analysis of PD-L1 expression in patients with relapsed NSCLC
    John, Nikolaus
    Schlintl, Verena
    Sassmann, Teresa
    Lindenmann, Joerg
    Fediuk, Melanie
    Wurm, Robert
    Douschan, Philipp
    Zacharias, Martin
    Kalson, Lipika
    Posch, Florian
    Absenger, Gudrun
    Brcic, Luka
    Jost, Philipp J.
    Terbuch, Angelika
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2024, 12 (04)
12345